Powell Andrew Kenneth William
SEC-identified person · CIK 1304113 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aclaris Therapeutics, Inc. ACRS | Director | filed 2017 - 2024 |
| Silverback Therapeutics, Inc. SPRY | Director | filed 2020 - 2022 |
| Lifecore Biomedical, INC. \DE\ LNDC | Director | filed 2018 - 2022 |
| Synthorx, Inc. THOR | Director | filed 2018 - 2020 |
| Medivation, INC. MDVN.OB | SVP, General Counsel & Crp Sec | filed 2015 - 2016 |
| Intermune INC ITMN | EVP, GC & Secretary | filed 2013 - 2014 |
| Critical Therapeutics INC CTRX | EVP, General Counsel | filed 2009 - 2013 |
| Imclone Systems INC/DE IMCL | SVP, General Counsel | filed 2008 - 2008 |
| Collagenex Pharmaceuticals INC CGPI | VP, G. Counsel and Corp. Sec. | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.